Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Revenues: |
| Title | 1,864.0 | 1,552.0 | 1,878.0 | 2,291.0 | 2,554.0 | 2,383.0 | 3,061.0 | 2,921.0 |
| Corporate and Other | 36.0 | 53.0 | 52.0 | 14.0 | 11.0 | 34.0 | 42.0 | 44.0 |
| Total revenues [+] | 514.0 | 418.0 | 485.0 | 557.0 | 637.0 | 593.0 | 673.0 | 737.0 |
| Net investment income | 618.0 | 611.0 | 539.0 | 411.0 | 463.0 | 478.0 | 537.0 | 508.0 |
| Revenue growth [+] | -19.3% | -29.5% | -27.9% | -24.4% | -15.1% | -10.3% | 0.3% | 10.7% |
| Title | -27.0% | -34.9% | -38.6% | -21.6% | -14.8% | -5.4% | 0.6% | 17.6% |
| Corporate and Other | 227.3% | 55.9% | 23.8% | -68.2% | -80.4% | -19.0% | -30.0% | -12.0% |
| Cost of goods sold | 755.0 | 677.0 | 734.0 | 796.0 | 839.0 | 823.0 | 932.0 | 894.0 |
| Gross profit | -241.0 | -259.0 | -249.0 | -239.0 | -202.0 | -230.0 | -259.0 | -157.0 |
| Gross margin | -46.9% | -62.0% | -51.3% | -42.9% | -31.7% | -38.8% | -38.5% | -21.3% |
| Selling, general and administrative [+] | 550.0 | 420.0 | 543.0 | 747.0 | 930.0 | 844.0 | 1,034.0 | 1,010.0 |
| Sales and marketing | 550.0 | 420.0 | 543.0 | 747.0 | 930.0 | 844.0 | 1,034.0 | 1,010.0 |
| Other selling, general and administrative | | | | | | | | |
| Equity in earnings | 1.0 | | -31.0 | | 14.0 | 2.0 | 10.0 | 27.0 |
| Other operating expenses | -1,513.0 | -1,170.0 | -633.0 | -1,388.0 | -1,425.0 | -1,192.0 | -2,192.0 | -2,025.0 |
| EBITDA [+] | 723.0 | 491.0 | -190.0 | 402.0 | 307.0 | 120.0 | 909.0 | 885.0 |
| EBITDA growth | 135.5% | 309.2% | -120.9% | -54.6% | -76.6% | -86.0% | 20.2% | 0.9% |
| EBITDA margin | 140.7% | 117.5% | -39.2% | 72.2% | 48.2% | 20.2% | 135.1% | 120.1% |
| Depreciation and amortization | 151.0 | 134.0 | 22.0 | 131.0 | 120.0 | 115.0 | 105.0 | 252.0 |
| EBIT [+] | 572.0 | 357.0 | -212.0 | 271.0 | 187.0 | 5.0 | 804.0 | 633.0 |
| EBIT growth | 205.9% | 7040.0% | -126.4% | -57.2% | -84.5% | -99.3% | 23.9% | -18.5% |
| EBIT margin | 111.3% | 85.4% | -43.7% | 48.7% | 29.4% | 0.8% | 119.5% | 85.9% |
| Non-recurring items | 197.0 | 385.0 | -274.0 | -166.0 | -575.0 | -584.0 | 86.0 | -320.0 |
| Interest expense | 43.0 | 42.0 | 26.0 | 28.0 | 31.0 | 30.0 | 31.0 | 27.0 |
| Interest expense | 43.0 | 42.0 | 26.0 | 28.0 | 31.0 | 30.0 | 31.0 | 27.0 |
| Other income (expense), net | | -4.0 | | | | -3.0 | | |
| Pre-tax income | 332.0 | -74.0 | 36.0 | 409.0 | 731.0 | 556.0 | 687.0 | 926.0 |
| Income taxes | 90.0 | 14.0 | -36.0 | 115.0 | 202.0 | 156.0 | 158.0 | 213.0 |
| Tax rate | 27.1% | | | 28.1% | 27.6% | 28.1% | 23.0% | 23.0% |
| Minority interest | 24.0 | -29.0 | 3.0 | 5.0 | 6.0 | 2.0 | 6.0 | 5.0 |
| Earnings from continuing ops | 219.0 | -59.0 | 68.0 | 289.0 | 537.0 | 400.0 | 533.0 | 735.0 |
| Earnings from discontinued ops | | | | | | | | -3.0 |
| Net income | 219.0 | -59.0 | 68.0 | 289.0 | 537.0 | 400.0 | 533.0 | 732.0 |
| Net margin | 42.6% | -14.1% | 14.0% | 51.9% | 84.3% | 67.5% | 79.2% | 99.3% |
| |
| Basic EPS [+] | $0.81 | ($0.22) | $0.25 | $1.06 | $1.93 | $1.42 | $1.87 | $2.60 |
| Growth | -58.0% | -115.4% | -86.8% | -59.2% | 1.2% | -31.4% | -67.0% | -7.7% |
| Diluted EPS [+] | $0.81 | ($0.22) | $0.25 | $1.05 | $1.92 | $1.41 | $1.86 | $2.58 |
| Growth | -58.0% | -115.4% | -86.8% | -59.3% | 1.5% | -31.4% | -67.0% | -7.7% |
| |
| Dividends per share [+] | $0.45 | $0.45 | $0.45 | $0.44 | $0.44 | $0.44 | $0.44 | $0.40 |
| Growth | 2.3% | 2.3% | 2.0% | 10.0% | 22.2% | 22.2% | 17.3% | 21.2% |
| |
| Shares outstanding (basic) [+] | 270.0 | 270.0 | 275.0 | 273.0 | 278.0 | 281.0 | 285.0 | 283.0 |
| Growth | -2.9% | -3.9% | -3.5% | -3.5% | -2.8% | -2.8% | 0.4% | -2.7% |
| Shares outstanding (diluted) [+] | 271.0 | 271.0 | 277.0 | 275.0 | 279.0 | 283.0 | 287.0 | 285.0 |
| Growth | -2.9% | -4.2% | -3.5% | -3.5% | -3.1% | -2.7% | 0.3% | -2.7% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|